Disclosure Panels Details Page

Multiple Myeloma/Systemic Light Chain Amyloidosis/Waldenström Macroglobulinemia Panel - Disclosures as of 02/26/2024

Panel Member
(Spouse/Domestic Partner/Dependent)
Clinical Research Support/Data Safety Monitoring Board Scientific Advisory Boards, Consultant, or Expert Witness Promotional Advisory Boards, Consultant, or Speakers Bureau Employment/ Governing Board, Patent, Equity, or Royalty Date Completed
Kehinde Adekola MSCI,MD Blood and Marrow Transplant Clinical Trials Network - BMT CTN
NHLBI Data and Safety Monitoring Board (DSMB)
None None None 07/17/2023
Larry Anderson, Jr. PhD,MD AbbVie, Inc.
Bristol Myers Squibb
Cellectar
GSK
Janssen Pharmaceutica Products, LP
Prothena
AbbVie, Inc.
BeiGene
Bristol Myers Squibb
Celgene Corporation
Cellectar
GSK
Janssen Pharmaceutica Products, LP
Prothena
sanofi-aventis U.S.
None None 10/24/2023
Muhamed Baljevic MD None Bristol Myers Squibb
Janssen Biotech
Sanofi-Genzyme
CancerNetwork
Cardinal Health
Curio Science
NCCN
OncLive
Targeted Oncology
None 11/04/2023
Rachid Baz MD AbbVie, Inc.
arvinas
Bristol Myers Squibb
Daiichi- Sankyo Co.
Janssen Pharmaceutica Products, LP
Karyopharm Therapeutics
Marker Therapeutics
Pfizer Inc.
pionyr immunotherapeutics
quantum leap healthcare collaborative
Regeneron Pharmactcls
SeaGen
Zymeworks
Bristol Myers Squibb
GSK
Janssen Pharmaceutica Products, LP
cancer network
curio science
HIKMA cancer network
SOHO MENA
None 11/06/2023
Marian Birkeland PhD None None None None 10/17/2023
Nicole Blankenhorn None None None None 09/19/2023
Natalie Callander MD None None None None 02/22/2024
Erica Campagnaro MD None None None None 02/09/2024
Jorge Castillo MD AbbVie, Inc.
AstraZeneca Pharmaceuticals LP
BeiGene
Cellectar
Eli Lilly and Company
Pharmacyclics
AbbVie, Inc.
BeiGene
Cellectar
Janssen Pharmaceutica Products, LP
Kite Pharma
LOXO
Pharmacyclics
None None 11/07/2023
Caitlin Costello MD Multiple Myeloma Research Foundation Celgene Corporation
Janssen Pharmaceutica Products, LP
Pfizer Inc.
Regeneron Pharmactcls
Takeda Pharmaceuticals North America, Inc.
None None 11/27/2023
Christopher D'Angelo MD BeiGene
Bristol Myers Squibb
Curis Inc
Fate Therapeutics
None AbbVie, Inc.
Bristol Myers Squibb
SeaGen
None 02/19/2024
Benjamin Derman MD Amgen Inc.
Bristol Myers Squibb
GSK
Janssen Pharmaceutica Products, LP
Novartis Pharmaceuticals Corporation
Bristol Myers Squibb COTA, INC.
Janssen Pharmaceutica Products, LP
None 01/17/2024
Srinivas Devarakonda MD None None None None 11/29/2023
Sarah DeVincenzo PharmD,BCPS None None None None 10/09/2023
Mary Dwyer MS None None None None 02/12/2024
Noura Elsedawy MD GSK None None Vyriad 09/26/2023
Meghan Fay OCN,RN,BSN None None None None 01/10/2024
Amandeep Godara MD None None None None 12/18/2023
Kelly Godby MD None None None None 02/20/2024
Kristina Gregory MSN,RN None None None None 01/10/2024
Evelyn Handel PharmD,BCPS,BCOP None None None None 02/02/2024
Erin Hesler None None None None 12/22/2023
Jens Hillengass MD,PhD Amgen Inc.
Bristol Myers Squibb
Fate therapeutics
Gilead Sciences, Inc.
GSK
Harpoon
IGM Biosciences, Inc.
Janssen Pharmaceutica Products, LP
Pfizer Inc.
Poseida
Prothena
sanofi-aventis U.S.
Aptitude Health
GSK
Intellisphere
Janssen Pharmaceutica Products, LP
Oncopeptides
Prothena
sanofi-aventis U.S.
Sebia
Skyline
None None 02/02/2024
Leona Holmberg PhD,MD Bristol Myers Squibb
ITeos
Merck & Co., Inc.
sanofi-aventis U.S.
Takeda Pharmaceuticals North America, Inc.
Bioline RX None Up-To-Date 12/26/2023
Myo Htut MD Celgene Corporation
Janssen Pharmaceutica Products, LP
None None None 11/03/2023
Carol Ann Huff MD Glenmark / Ichnos
Prothena
sanofi-aventis U.S. None None 01/31/2024
Malin Hultcrantz PhD,MD AbbVie, Inc.
BeiGene
Daiichi- Sankyo Co.
GSK
Springworks
Bristol Myers Squibb
GSK
Johnson & Johnson
None None 02/15/2024
Yubin Kang MD Karyopharm Therapeutics
Takeda Pharmaceuticals North America, Inc.
None None None 02/08/2024
Emily Kovach None None None None 01/08/2024
Rashmi Kumar PhD None None None None 12/06/2023
Shaji Kumar MD AbbVie, Inc.
Allogene
Arcellx
Bristol Myers Squibb
Carsgen
GSK
Janssen Pharmaceutica Products, LP
Roche Laboratories, Inc.
Takeda Pharmaceuticals North America, Inc.
AbbVie, Inc.
Bristol Myers Squibb
GSK
Pfizer Inc.
Regeneron Pharmaceuticals, Inc.
Roche Laboratories, Inc.
sanofi-aventis U.S.
Takeda Pharmaceuticals North America, Inc.
None None 11/19/2023
Sarah Larson MD AbbVie, Inc.
Allogene
Bristol Myers Squibb
Celgene Corporation
Janssen Pharmaceutica Products, LP
Juno Therapeutics, Inc.
Pfizer Inc.
sanofi-aventis U.S.
1200 Pharma
TORL Biotherapeutics
Oncovalent None 02/03/2023
Hans Lee MD Allogene Therapeutics
Amgen Inc.
Bristol Myers Squibb
GSK
Janssen Pharmaceutica Products, LP
National Cancer Institute
Regeneron Pharmaceuticals, Inc.
Takeda Pharmaceuticals North America, Inc.
AbbVie, Inc.
Bristol Myers Squibb
GSK
Janssen Pharmaceutica Products, LP
Regeneron Pharmactcls
sanofi-aventis U.S.
None None 12/05/2023
Michaela Liedtke MD AbbVie, Inc.
Allogene
Biomea
Bristol Myers Squibb
Caelum
Gilead Sciences, Inc.
Janssen Pharmaceutica Products, LP
SeaGen
AbbVie, Inc.
Bristol Myers Squibb
Nexcella
None None 01/07/2024
Thomas Martin MD Amgen Inc.
Bristol Myers Squibb
Janssen Pharmaceutica Products, LP
sanofi-aventis U.S.
Eli Lilly and Company
GSK
Pfizer Inc.
None None 10/23/2023
John Murphy None None None None 12/04/2023
Jim Omel MD None None None None 02/16/2024
Donna Powell DHSc,CMD,RT(T) None None None None 10/27/2023
Timothy Robinson PhD,MD I have a lab and conduct research that has been previously funded by the NIH/NCI and upcoming funding from the American Cancer Society
Wife/spouse is co-leader of cancer prevention and control for Yale Cancer Center. She conducts NIH and ACS funded research as a principle investigator. No perceived conflicts of interest.
Kite Pharma None I have patents related to splicing-based therapeutics and theragnostics. None are currently licensed. Unrelated to multiple myeloma or NCCN guidelines. 11/28/2023
Aaron Rosenberg MD Biomea
GSK
Kangpu Biopharmaceuticals
Sorento
Takeda Pharmaceuticals North America, Inc.
Kangpu Biopharmaceuticals None None 04/12/2023
Mark Schroeder MD Fate Therapeutics, Inc.
Ichnos Sciences SA
Incyte Corporation
Janssen Pharmaceutica Products, LP
Karyopharm Therapeutics
Kura Oncology (through IQVIA CRO)
Marker Therapeutics (through Advarra CRO)
Sorrento (through Advarra CRO)
Takeda Pharmaceuticals North America, Inc.
None None None 12/13/2023
Daniel Sherbenou PhD,MD Karyopharm Therapeutics
Pfizer Inc.
sanofi-aventis U.S.
None None None 01/31/2024
Attaya Suvannasankha MD Bristol Myers Squibb
GSK
Janssen Pharmaceutica Products, LP
Regeneron Pharmactcls
SUTRO Biopharma, Inc.
Bristol Myers Squibb
GSK
Janssen Pharmaceutica Products, LP
None None 02/08/2024
Jason Valent MD AbbVie, Inc.
Alexion Pharmaceuticals, Inc.
Allogene therapeutics
Amgen Inc.
Bristol Myers Squibb
GSK
Janssen Pharmaceutica Products, LP
Pfizer Inc.
Pharmacyclics
Prothena Biosciences
None None none 01/23/2023
Asya Nina Varshavsky-Yanovsky PhD,MD Bristol Myers Squibb
Pfizer Inc.
Bristol Myers Squibb
GSK
Janssen Pharmaceutica Products, LP
Pfizer Inc.
None None 02/22/2024
Erin Vidic None None None None 12/15/2023
Dan Vogl MD AbbVie, Inc.
Active Biotech AB
Caelum Biosciences
CRISPR Therapeutics
Genentech, Inc.
GSK
Janssen Pharmaceutica Products, LP
Phosplatin Therapeutics
Takeda Pharmaceuticals North America, Inc.
AbbVie, Inc.
Genentech, Inc.
Takeda Pharmaceuticals North America, Inc.
None None 01/20/2024